期刊文献+

老年糖尿病患者脂蛋白(a)和纤维蛋白原水平变化的研究 被引量:4

Relationship of the Levels of Lipoprotein(a) and Fibrinogen(Fbg) in Old Diabetic Mellitus
下载PDF
导出
摘要 目的探讨老年糖尿病患者脂蛋白(a)[Lp(a)]和纤维蛋白原(Fbg)水平变化的临床意义。方法 测定50例老年糖尿病患者和28例糖尿病合并脑梗死患者的Lp(a)和纤维蛋白原(Fbg)含量。结果 糖尿病组及糖尿病合并脑梗死患者较正常组Lp(a)、Fbg显著升高(P<0.05)。结论 糖尿病患者体内存在高凝状态,Fbg和Lp(a)水平升高与糖尿病血管并发症的发生和发展密切相关,易致血栓形成。 Objective To study the relationship between lipoprotein (a) [Lp(a)]and fibrinogen(Fbg)in old diabetic mellitus(DM). Methods The levels of serum Lp(a) ,Fbg were measured in a group of elderly DM and its control. Results The DM groups with and without cerebral infraction had higher values than the control in the following parameters:Lp(a) ,Fbg(P <0.05). Patients with cerebral infraction also had higher values of Lp(a), Fbg(P < 0.05) than the DM groups. Conclusion There are increased coagulation, decreased fibrinolysis activities in the eldly patients with DM,especially with cerebral infraction. Combined with increased Lp(a) ,these may aggravate pathophyssiological process. All these changes have close relationship with the vascular complications of DM and its severity.
出处 《血栓与止血学》 2005年第2期81-82,共2页 Chinese Journal of Thrombosis and Hemostasis
关键词 糖尿病 脂蛋白 纤维蛋白原 Diabetic mellitus Lipoprotein(a) Fibrinogen
  • 相关文献

参考文献6

  • 1[1]Eremc,DegerO,BostanM,etal. Plasmalipoprotein (a) levels in Turkish NIDDM patients with and without vascular diabetic cimplications[J]. Acta Gardiol ,1999 , 54: 203 ~207.
  • 2[2]Semon Li, Deluca C, Jenner JL, et al. Lipoprotein (a) - cholesterol and coronary heart diease in the framingham heart study[J]. Clin Chem,1999,45:1039 ~ 1046.
  • 3[3]Testa R,Bontigli AR,Sirolla C ,et al. A strong inverse relationship between PAI-1 and LP (a) in hypertensive type 2 diabetic patients[ J]. Diabete Natr Metab,1999,12:400~406.
  • 4[4]Zhang J,Ren S,Shen GX,et al. Glycation amplifies lipoprotein(a)induced alterations in the generation of fibrinolytic regulators from human vascular endothelial cells[ J ]. Atheroscherosis ,2000,150:299 ~ 308.
  • 5郭郁郁,胡钧培,王鸿利.糖尿病血管内皮细胞功能与血栓形成[J].国外医学(临床生物化学与检验学分册),2003,24(3):131-132. 被引量:8
  • 6汪芳,赵迎,胡锦章,满咏,王华.冠心病患者脂蛋白(a)和纤维蛋白原血浓度与冠状动脉狭窄间的关系[J].中国动脉硬化杂志,1997,5(3):246-248. 被引量:11

二级参考文献16

  • 1蒋雷,国汉邦,赵满仓,刘菊林,李健斋.抗载脂蛋白(a)单克隆抗体的制备及其应用[J].中华医学检验杂志,1995,18(3):136-139. 被引量:7
  • 2Dedov II, Shestakov MV, Kochemasova TV, et al. Endothelial dysfunction in the development of vascular complications in diabetes mellitus[J]. Ross Fiziol Zh Im I M Sechenova, 2001,87 (8):1073-1084.
  • 3Bombeli T, Mueller M, Haeberi A. Anticoagulant properties of the vascular endothelium [J]. Thromb Haemost,1997,77:408-423.
  • 4Isermann B, Hendrickson SB, Zogg M,et al. Endothelium-specific loss of murine thrombomodulin disrupts the protein C anticoagulant pathway and causes juvenile-onset thrombosis [J]. J Clin Invest, 2001, 108 (4) :537-546.
  • 5Leurs PB, van Oerle R, Wolffenbuttel BH, et al. Increased tissue factor pathway inhibitor (TFPI)and coagulation in patients with insulin-dependent diabetes mellitus [J].Thromb Haemost, 1997,77(3): 472-476.
  • 6Vu T H, Hung DT,Wheaton VI, et al. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor aetivition[J]. Cell, 1991,64: 1057-1068.
  • 7Esmon CT. Protein C anticoagulant pathway and its way role in controlling microvascular thrombosis and inflammation[J]. Crit Care Med,2001,29(7 Suppl) :S48-51.
  • 8Bastard JP, Pieroni L, Hainque B. Relaionship between plasma plasminogen activator inhibitor 1 and insulin resistance[J]. Diabetes Metab Res Rev,2000,16(3):192-201.
  • 9Abdu TA, Elhadd T, Pfeifer M, Clayton RN. Endothelial dysfunction in endocrine disease [J]. Trends Endocrino Metab,2001,12(6) :257-265.
  • 10Repo H, Harlan JM. Mechanisms and consequences of phagocyte adhesion to endothelium[J]. Ann Med, 1999,31:156-165.

共引文献17

同被引文献23

  • 1田清武,周淑华,伦立民.心脑血管疾病及糖尿病与血清脂蛋白(a)的关系[J].齐鲁医学杂志,2005,20(2):115-116. 被引量:1
  • 2周碧蓉,徐岩,吴继雄,徐元宏,许邦龙.冠心病患者血浆纤维蛋白原、血清脂蛋白(a)、血小板测定及其意义[J].心血管康复医学杂志,2005,14(6):514-516. 被引量:2
  • 3龚建明,黎龙群,余志彬.血脂水平与2型糖尿病伴发大血管病变关系的探讨[J].现代医药卫生,2007,23(8):1201-1202. 被引量:4
  • 4Nicola SP, Kruidenier LM, Rouwet EV, et al. Pocket doppler and vascular laboratory equipment yield comparable results for ankle brachial index measurement. BMC Cardiovasc Disord 2008 ;8 : 26.
  • 5Meves SH, Diehm C, Berger K, et al. Peripheral arterial dis- ease as an independent predictor for excess stroke morbidity and mor- tality in primary - care patients: 5 - year results of the get ABI study. Cerebrovasc Dis 2010 ;29 (6) :546 - 554.
  • 6Lee IT, Huang CN, Lee W J, et al. High total - to - HDL cholesterol ratio predicting deterioration of ankle brachial index in Asi- an type 2 diabetic subjects. Diabetes Res Clin Pract 2008 ;79 ( 3 ) : 419 -426.
  • 7Albahrani A, Alkindi M, Marks E, et al. Lipoprotein (a) : an independent risk factor for ischemic heart disease that is dependent on triglycerides in subjects with type 2 diabetes mellitus. Lipids Health Dis 2007;10: 6-26.
  • 8Boras J, Ljubic S, Car N, et al. Lipoprotein (a) predicts progression of carotid artery intima - media thickening in patients with type 2diabetes: A four - year follow - up. Wien Klin Wochenschr 2010 ; 122 : 159 - 164.
  • 9Margolis DJ, Hofstad O, Feldman HI. Association between renal failure and foot ulcer or lower - extremity amputation in patients with diabetes. Diabetes Care 2008 ;31 : 1331 - 1336.
  • 10Harmel AP,Ryan D,Thompson R.Glycohemoglobin assessment program:glycated hemoglobin and epidemiologic variables in patients with type 2 diabetes.Endocr Pract,2002,8 (3):184~190.

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部